https://www.selleckchem.com/products/vx-11e.html
This article highlights how the GIP receptor expressed by the brain impacts obesity-related pathogenesis.Gastric inhibitory peptide (GIP) is best known for its role as an incretin hormone in control of blood glucose concentrations. As a classic satiation signal, however, the literature illustrates a mixed picture of GIP involvement with an at best weak anorectic response profile being reported for GIP receptor (GIPR) signaling. Not surprisingly, the pursuit of exploiting the GIP system as a therapeutic target for diabetes and obesity has
Gefällt mir
Kommentar
Teilen
